Skip to main content
Log in

Frequency and Factors Associated with Small Intestinal Bacterial Overgrowth in Patients with Cirrhosis of the Liver and Extra Hepatic Portal Venous Obstruction

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Spontaneous bacterial peritonitis (SBP), a common complication of cirrhosis of liver, might result from translocation of bacteria from the small bowel. However, there is scanty data on frequency of small intestinal bacterial overgrowth (SIBO) in patients with cirrhosis of the liver. There are no data on SIBO in patients with extra-hepatic portal venous obstruction (EHPVO) in the literature. A total of 174 patients with cirrhosis of the liver, 28 with EHPVO and 51 healthy controls were studied for SIBO using glucose hydrogen breath test (GHBT). Persistent rise in breath hydrogen 12 ppm above basal (at least two readings) was considered diagnostic of SIBO. Of 174 patients (age 47.2 ± 11.9 years, 80.5% male) with cirrhosis due to various causes, 67 (38.5%) were in Child’s class A, 70 (40.2%) class B and 37 (21.7%) class C. Of the 174 patients with cirrhosis, 42 (24.14%) had SIBO as compared to 1 of 51 (1.9%) healthy controls (P < 0.0001). Patients with EHPVO had similar frequency of SIBO compared to healthy controls [2/28 (7.14%) vs 1/51 (1.97%), P = ns]. Frequency of SIBO in Child’s A, B and C was comparable [13 (18.6%) vs 16 (23.9%) and 13 (35.1%), respectively; P = ns]. Presence of SIBO were not related to ascites, etiology of cirrhosis, and degree of liver dysfunction. SIBO is common in patients with cirrhosis of the liver. Patients with EHPVO do not have higher frequency of SIBO than healthy subjects. SIBO in cirrhosis is not related to the degree of derangement in liver function or of portal hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Nobre SR, Cabral JE, Gomes JJ, Leitão MC. In-hospital mortality in spontaneous bacterial peritonitis: a new predictive model. Eur J Gastroenterol Hepatol. 2008;20(12):1176–1181. doi:10.1097/MEG.0b013e32830607a2.

    Article  PubMed  Google Scholar 

  2. Angeloni S, Leboffe C, Parente A, et al. Effcacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol. 2008;14(17):2757–2762. doi:10.3748/wjg.14.2757.

    Article  CAS  PubMed  Google Scholar 

  3. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993;18(3):353–358. doi:10.1016/S0168-8278(05)80280-6.

    Article  CAS  PubMed  Google Scholar 

  4. Sheer TA, Runyon BA. Spontaneous bacterial Peritonitis. Dig Dis. 2005;23:39–46. doi:10.1159/000084724.

    Article  PubMed  Google Scholar 

  5. Puri AS, Puri J, Ghoshal UC, et al. Frequency, microbial spectrum and outcome of spontaneous bacterial peritonitis in north India. Indian J Gastroenterol. 1996;15(3):86–89.

    CAS  PubMed  Google Scholar 

  6. Sánchez E, Casafont F, Guerra A, de Benito I, Pons-Romero F. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis. Rev Esp Enferm Dig. 2005;97(11):805–814.

    Article  PubMed  Google Scholar 

  7. Bauer TM, Steinbrückner B, Brinkmann FE, et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol. 2001;96(10):2962–2967. doi:10.1111/j.1572-0241.2001.04668.x.

    Article  CAS  PubMed  Google Scholar 

  8. Chesta J, Silva M, Thompson L, del Canto E, Defilippi C. Bacterial overgrowth in small intestine in patients with liver cirrhosis. Rev Med Chil. 1991;119(6):626–632.

    CAS  PubMed  Google Scholar 

  9. Casafont Morencos F, de las Heras Castaño G, Martín Ramos L, López Arias MJ, Ledesma F, Pons Romero F. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci. 1995;40(6):1252–1256. doi:10.1007/BF02065533.

    Article  Google Scholar 

  10. Chen M, Sun G, et al. Small bowel bacterial overgrowth and endotoxemia in cirrhosis. Zhonghua Nei Ke Za Zhi. 2002;41(7):459–461.

    PubMed  Google Scholar 

  11. Chang CS, Chen GH, Lien HC, Yeh HZ. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 1998;28(5):1187–1189. doi:10.1002/hep.510280504.

    Article  CAS  PubMed  Google Scholar 

  12. Chang CS, Yang SS, Kao CH, Yeh HZ. Chen GHSmall intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis. Scand J Gastroenterol. 2001;36(1):92–96. doi:10.1080/00365520150218110.

    Article  CAS  PubMed  Google Scholar 

  13. Gunnarsdottir SA, Sadik R, Shev S, et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol. 2003;98(6):1362–1370. doi:10.1111/j.1572-0241.2003.07475.x.

    Article  PubMed  Google Scholar 

  14. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–649. doi:10.1002/bjs.1800600817.

    Article  CAS  PubMed  Google Scholar 

  15. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol. 1994;21(5):792–796. doi:10.1016/S0168-8278(94)80241-6.

    Article  CAS  PubMed  Google Scholar 

  16. Yang CY, Chang CS, Chen GH. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests. Scand J Gastroenterol. 1998;33(8):867–871. doi:10.1080/00365529850171549.

    Article  CAS  PubMed  Google Scholar 

  17. Bode C, Kolepke R, Schäfer K, Bode JC. Breath hydrogen excretion in patients with alcoholic liver disease–evidence of small intestinal bacterial overgrowth. Z Gastroenterol. 1993;31(1):3–7.

    CAS  PubMed  Google Scholar 

  18. Gupta N, Sahni V, Singh P, Das A, Kar P. Spontaneous bacterial peritonitis in isolated splenic vein thrombosis with portal hypertension. Indian J Gastroenterol. 2006;25:263–264.

    PubMed  Google Scholar 

  19. Quera PR, Quigley EM, Madrid SAM. Small intestinal bacterial overgrowth. An update. Rev Med Chil. 2005;133(11):1361–1370.

    Google Scholar 

  20. Ghoshal UC, Dhar K, Chaudhuri S, Pal BB, Pal AK, Banerjee PK. Esophageal motility changes after endoscopic intravariceal sclerotherapy with absolute alcohol. Dis Esophagus. 2000;13(2):148–151. doi:10.1046/j.1442-2050.2000.00104.x.

    Article  CAS  PubMed  Google Scholar 

  21. Sadik R, Abrahamsson H, Björnsson E, Gunnarsdottir A, Stotzer PO. Etiology of portal hypertension may influence gastrointestinal transit. Scand J Gastroenterol. 2003;38(10):1039–1044. doi:10.1080/00365520310004939.

    Article  CAS  PubMed  Google Scholar 

  22. Reilly JA Jr, Quigley EM, Forst CF, Rikkers LF. Small intestinal transit in the portal hypertensive rat. Gastroenterology. 1991;100(3):670–674.

    PubMed  Google Scholar 

  23. Madrid AM, Cumsille F, Defilippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci. 1997;42(4):738–742. doi:10.1023/A:1018899611006.

    Article  CAS  PubMed  Google Scholar 

  24. Savarino V, Mela GS, Zentilin P, et al. Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. Hepatology. 1996;25(2):152–157. doi:10.1016/S0168-8278(96)80067-5.

    Article  CAS  Google Scholar 

  25. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology. 1984;4(1):53–58. doi:10.1002/hep.1840040109.

    Article  CAS  PubMed  Google Scholar 

  26. Lewis SJ, Franco S, Young G, O’Keefe SJ. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996;10(4):557–561. doi:10.1046/j.1365-2036.1996.d01-506.x.

    Article  CAS  PubMed  Google Scholar 

  27. Pereira SP, Gainsborough N, Dowling RH. Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly. Aliment Pharmacol Ther. 1998;12(1):99–104. doi:10.1046/j.1365-2036.1998.00275.x.

    Article  CAS  PubMed  Google Scholar 

  28. Nelis GF, Engelage AH, Samson G. Does long-term inhibition of gastric acid secretion with omeprazole lead to small intestinal bacterial overgrowth? Neth J Med. 1994;45(3):93–100.

    CAS  PubMed  Google Scholar 

  29. Bauer TM, Schwacha H, Steinbrückner B, et al. Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol. 2000;33(3):382–386. doi:10.1016/S0168-8278(00)80273-1.

    Article  CAS  PubMed  Google Scholar 

  30. Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome, and its relationship with oro-cecal transit time. Indian J Gastroenterol. 2006;25(1):6–10.

    PubMed  Google Scholar 

  31. Rana SV, Sinha SK, Sharma S, Kaur H, Bhasin DK, Singh K. Effect of predominant Methanogenic Flora on outcome of lactose hydrogen breath test in controls and irritable bowel syndrome patients of North India. Dig Dis Sci. 2009;54(1):132–135. doi:10.1007/s10620-008-0315-x.

    Article  CAS  PubMed  Google Scholar 

  32. Llovet JM, Rodriguez-Iglesias P, Moitinho E, et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. J Hepatol. 1997;26:88–95. doi:10.1016/S0168-8278(97)80014-1.

    Article  CAS  PubMed  Google Scholar 

  33. Umgelter A, Reindl W, Miedaner M, Schmid RM, Huber W. Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis. Infection. 2009;37(1):2–8. doi:10.1007/s15010-008-8060-9.

    Article  CAS  PubMed  Google Scholar 

  34. Madrid AM, Hurtado C, Venegas M, Cumsille F, Defilippi C. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am J Gastroenterol. 2001;96(4):1251–1255. doi:10.1111/j.1572-0241.2001.03636.x.

    Article  CAS  PubMed  Google Scholar 

  35. Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites. J Gastroenterol Hepatol. 2005;20(4):599–605. doi:10.1111/j.1440-1746.2005.03796.x.

    Article  CAS  PubMed  Google Scholar 

  36. Pardo A, Bartolí R, Lorenzo-Zúñiga V, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology. 2000;31(4):858–863. doi:10.1053/he.2000.5746.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Uday C. Ghoshal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lakshmi, C.P., Ghoshal, U.C., Kumar, S. et al. Frequency and Factors Associated with Small Intestinal Bacterial Overgrowth in Patients with Cirrhosis of the Liver and Extra Hepatic Portal Venous Obstruction. Dig Dis Sci 55, 1142–1148 (2010). https://doi.org/10.1007/s10620-009-0826-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-0826-0

Keywords

Navigation